Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose 23. Oktober 2018
Suchen
Gastroplattform
Leberzirrhose
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1272  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 25428  
   
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Open Access Maced J Med Sci
Mehinovic L, Islamagic E, Husic-Selimovic A, Kurtovic-Kozaric A, Vukobrat-Bijedic Z, Suljevic D.
PMID: 30337985 [PubMed]


Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial.
BMJ Open
Hjorth M, Sjöberg D, Svanberg A, Kaminsky E, Langenskiöld S, Rorsman F.
PMID: 30337316 [PubMed - in process]


Prognosis of cirrhotic patients admitted to Emergency Departments: A multicenter study.
Am J Emerg Med
Javaud N, Bonnin L, Lapostolle F, Boubaya M, Bardis A, Dufau R, Ghazali A, Reuter PG, Pateron D, Adnet F.
PMID: 30337088 [PubMed - as supplied by publisher]


Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
Clin Lab
Afify SM, Tabll A, Nawara HM, Kassas ME, Elfert A, Seno M, El-Kousy S.
PMID: 30336529 [PubMed - in process]


Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research.
Dig Dis Sci
Murphy SL, Tapper EB, Blackwood J, Richardson JK.
PMID: 30327964 [PubMed - as supplied by publisher]


Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
Front Psychiatry
Mosoni C, Dionisi T, Vassallo GA, Mirijello A, Tarli C, Antonelli M, Sestito L, Rando MM, Tosoni A, De Cosmo S, Gasbarrini A, Addolorato G.
PMID: 30327620 [PubMed]


Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis.
J Clin Med
Surov A, Paul L, Meyer HJ, Schob S, Engelmann C, Wienke A.
PMID: 30326652 [PubMed]


Immunodeficiency caused by cirrhosis.
Clin Exp Hepatol
Tuchendler E, Tuchendler PK, Madej G.
PMID: 30324140 [PubMed]


Cirrhosis, Operative Trauma, Transfusion, and Mortality: A Multicenter Retrospective Observational Study.
Cureus
Isbell C, Cohn SM, Inaba K, O'Keeffe T, De Moya M, Demissie S, Ghneim M, Davis ML.
PMID: 30324043 [PubMed]


Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.
Hepatology
Abraldes JG, Trebicka J, Chalasani N, D'Amico G, Rockey D, Shah V, Bosch J, Garcia-Tsao G.
PMID: 30318607 [PubMed - as supplied by publisher]


Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
Eur J Gastroenterol Hepatol
Yosry A, Soliman ZA, Eletreby R, Hamza I, Ismail A, Elkady MA.
PMID: 30312183 [PubMed - as supplied by publisher]


Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs.
Int J Mol Sci
Nishikawa K, Osawa Y, Kimura K.
PMID: 30308992 [PubMed - in process]


Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: a multicenter study.
Hepatol Res
Itokawa N, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Arai T, Iwashita AN, Kondo C, Mikami S, Asano T, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K.
PMID: 30307682 [PubMed - as supplied by publisher]


Retrospectively Seroprevalence Study on Anti-HEV-IgG antibody in patients with chronic hepatitis or liver cirrhosis in a Chinese teaching hospital.
J Med Virol
Yang H, Wu J, Yuan Y, Huang W, Jia B.
PMID: 30307619 [PubMed - as supplied by publisher]


Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Clin Exp Hepatol
Butterworth RF, Kircheis G, Hilger N, McPhail MJW.
PMID: 30302048 [PubMed]


A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.
J Clin Exp Hepatol
Mehta G, Rousell S, Burgess G, Morris M, Wright G, McPherson S, Frenette C, Cave M, Hagerty DT, Spada A, Jalan R.
PMID: 30302038 [PubMed]


A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease.
Indian J Endocrinol Metab
Punekar P, Sharma AK, Jain A.
PMID: 30294575 [PubMed]


Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.
United European Gastroenterol J
Zhu J, Qi X, Yu H, Yoshida EM, Mendez-Sanchez N, Zhang X, Wang R, Deng H, Li J, Han D, Guo X.
PMID: 30288280 [PubMed]


Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.
Am J Med Sci
Flamm SL.
PMID: 30286824 [PubMed - in process]


Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.
Hepatol Int
Maslennikov R, Pavlov C, Ivashkin V.
PMID: 30284684 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 25428    Seite 1 von 1272  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1